{"indexed":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T04:59:15Z","timestamp":1550120355654},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":2344,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/j.1365-2265.2008.03342.x","type":"article-journal","created":{"date-parts":[[2008,8,20]],"date-time":"2008-08-20T10:33:14Z","timestamp":1219228394000},"page":"522-526","source":"Crossref","is-referenced-by-count":6,"title":"No difference between strontium ranelate (SR) and calcium\/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial","prefix":"10.1111","volume":"70","author":[{"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"Dimirtios G.","family":"Goulis","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Spiridon","family":"Gerou","sequence":"additional","affiliation":[]},{"given":"Iris","family":"Ballaouri","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[]},{"given":"Avraam","family":"Avramidis","sequence":"additional","affiliation":[]}],"member":"311","reference":[{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(98)00183-5","article-title":"Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women","volume":"24","author":"Ravn","year":"1999","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1359\/JBMR.0301243","article-title":"Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk","volume":"19","author":"Sarkar","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis","volume":"20","author":"Chen","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1185\/030079905X75096","article-title":"Development of an algorithm for using PINP to monitor treatment of patients with teriparatide","volume":"22","author":"Eastell","year":"2006","journal-title":"Current Medical Research and Opinion"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB6","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1359\/JBMR.050403","article-title":"Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover","volume":"20","author":"Nenonen","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcified Tissue International"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":"Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocrine Reviews"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB9","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB11","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jocd.2007.03.102","article-title":"The correction of BMD measurements for bone strontium content","volume":"10","author":"Blake","year":"2007","journal-title":"Journal of Clinical Densitometry"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1359\/jbmr.070607","article-title":"Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength","volume":"22","author":"Ammann","year":"2007","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/8756-3282(96)00080-4","article-title":"The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro","volume":"18","author":"Canalis","year":"1996","journal-title":"Bone"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2265.2008.03342.x-BIB15","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.bone.2005.07.029","article-title":"Strontium ranelate: a physiological approach for optimizing bone formation and resorption","volume":"38","author":"Marie","year":"2006","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S8756-3282(01)00484-7","article-title":"Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis","volume":"29","author":"Buehler","year":"2001","journal-title":"Bone"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB18","first-page":"2060","article-title":"Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial","volume":"87","author":"Meunier","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB19","first-page":"2129","article-title":"Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate","volume":"85","author":"Rittmaster","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/jn\/136.4.1126","article-title":"Vitamin D and African Americans","volume":"136","author":"Harris","year":"2006","journal-title":"Journal of Nutrition"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB22","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1210\/jc.2003-031979","article-title":"Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization","volume":"89","author":"Binkley","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2008-1046787","article-title":"Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized controlled trial","volume":"40","author":"Anastasilakis","year":"2008","journal-title":"Hormone and Metabolic Research"},{"issue":"Suppl. 6","key":"10.1111\/j.1365-2265.2008.03342.x-BIB25","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1007\/s001980070007","article-title":"Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporosis International"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB27","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1210\/en.2003-1127","article-title":"Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts","volume":"145","author":"Chattopadhyay","year":"2004","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2265.2008.03342.x-BIB28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bone.2007.08.043","article-title":"Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro","volume":"42","author":"Bonnelye","year":"2008","journal-title":"Bone"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2265.2008.03342.x-BIB29","first-page":"S129","article-title":"Strontium ranelate effect on proliferation and OPG expression in osteoblasts","volume":"78","author":"Brennan","year":"2006","journal-title":"Calcified Tissue International"}],"container-title":"Clinical Endocrinology","original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2008.03342.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T18:37:18Z","timestamp":1550083038000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":29,"journal-issue":{"published-print":{"date-parts":[[2009,4]]},"issue":"4"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1365-2265.2008.03342.x","relation":{"cites":[]},"ISSN":["0300-0664","1365-2265"],"subject":["Endocrinology, Diabetes and Metabolism"]}